New microscopy method provides unprecedented look at amyloid protein structure

June 04, 2020

WASHINGTON -- Neurodegenerative diseases such as Alzheimer's and Parkinson's are often accompanied by amyloid proteins in the brain that have become clumped or misfolded. A newly developed technique that measures the orientation of single molecules is enabling optical microscopy to be used, for the first time, to reveal nanoscale details about the structures of these problematic proteins.

Researchers from Washington University in St. Louis describe their new approach in Optica, The Optical Society's journal for high impact research.

"Neurodegenerative disorders such as Alzheimer's and Parkinson's diseases are leading causes of death all over the world," said Tianben Ding, co-first author of the new paper. "We hope our single-molecule orientation imaging approach can provide new insights into amyloid structure and possibly contribute to the future development of effective therapeutics against these diseases."

Biological and chemical processes in the brain are driven by complicated movements and interactions between molecules. Although most amyloid proteins may be non-toxic, the misfolding of even a few could eventually kill many neurons.

"We need imaging technologies that can watch these molecular movements in living systems to understand the fundamental biological mechanisms of disease," explained Matthew D. Lew, leader of the research team. "Amyloid and prion-type diseases like Alzheimer's, Parkinson's and diabetes are our first targets for this technology, but we see it being applied in many other areas too."

Selecting the best microscope

Lew's lab has developed several single-molecule super-resolution microscopy methods that measure the orientation and location of fluorescent molecules attached to single proteins. The orientation information is obtained by measuring not only the location of fluorescence in the sample but also characteristics of that light, such as polarization, which are typically ignored in most other microscopy approaches.

In their Optica article, the researchers described a performance metric they designed to characterize how sensitively various microscopes can measure orientations of fluorescent molecules. Using the new performance indicator, the researchers found that a microscope that splits fluorescence light into two polarization channels (x and y) provides superior and practical orientation measurements.

"The metric we developed calculates the performance of a particular microscope design 1,000 times faster than before," said Tingting Wu, co-first author of the work. "By measuring the orientations of single molecules bound to amyloid aggregates, the selected microscope enabled us to map differences in amyloid structure organization that cannot be detected by standard localization microscopes."

Since there is no artificial link between the fluorescent probes and amyloid surfaces, the probes' binding orientation to the amyloid surfaces conveys information about how the amyloid protein itself is organized. The researchers quantified how the orientations of fluorescent molecules varied each time one attached to an amyloid protein. Differences in these binding behaviors can be attributed to structure differences between amyloid aggregates. Because the method provides single-molecule information, the researchers could observe nanoscale differences between amyloid structures without averaging out details of local features.

Opportunities for long-term studies

"We plan to extend the method to monitor nanoscale changes within and between amyloid structures as they organize over hours to days," said Ding. "Long-term studies of amyloid aggregates may reveal new correlations between how amyloid proteins are organized and how quickly they grow or spontaneously dissolve."

The researchers note that the set-up they used for orientation-localization microscopy consisted of commercially available parts that are accessible to anyone performing single-molecule super-resolution microscopy. Their analysis code is available at https://github.com/Lew-Lab/RoSE-O.

"In optical microscopy and imaging, scientists and engineers have been pushing the boundaries of imaging to be faster, probe deeper and have higher resolution," said Lew. "Our work shows that one can shed light on fundamental processes in biology by, instead, focusing on molecular orientation, which can reveal details about the inner workings of biology that cannot be visualized by traditional microscopy."
-end-
Paper: T. Ding, T. Wu, H. Mazidi, O. Zhang, M. Lew, "Single-molecule orientation localization microscopy for resolving structural heterogeneities between amyloid fibrils," Optica 7, 6, 602 (2020).

DOI: https://doi.org/10.1364/OPTICA.388157

About Optica

Optica is an open-access, journal dedicated to the rapid dissemination of high-impact peer-reviewed research across the entire spectrum of optics and photonics. Published monthly by The Optical Society (OSA), Optica provides a forum for pioneering research to be swiftly accessed by the international community, whether that research is theoretical or experimental, fundamental or applied. Optica maintains a distinguished editorial board of more than 60 associate editors from around the world and is overseen by Editor-in-Chief Prem Kumar, Northwestern University, USA. For more information, visit Optica.

About The Optical Society

Founded in 1916, The Optical Society (OSA) is the leading professional organization for scientists, engineers, students and business leaders who fuel discoveries, shape real-life applications and accelerate achievements in the science of light. Through world-renowned publications, meetings and membership initiatives, OSA provides quality research, inspired interactions and dedicated resources for its extensive global network of optics and photonics experts. For more information, visit osa.org.

Media Contacts:

Aaron Cohen
(301) 633-6773
aaroncohenpr@gmail.com

mediarelations@osa.org

The Optical Society

Related Neurodegenerative Diseases Articles from Brightsurf:

Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases
Researchers from the Institut national de la recherche scientifique (INRS) have shown that nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases.

First 'pathoconnectome' could point toward new treatments for neurodegenerative diseases
Scientists from the John A. Moran Eye Center at the University of Utah have achieved another first in the field of connectomics, which studies the synaptic connections between neurons.

Unlocking the mystery of tau for treatment of neurodegenerative diseases
A team of researchers from various collaborating universities and hospitals in Japan has uncovered crucial molecular details regarding the activity of the ''tau'' protein, promising to revolutionize the therapy of tau-induced neurodegenerative diseases.

Investigational drug stops toxic proteins tied to neurodegenerative diseases
An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), may reduce the protein's buildup and neurological decline associated with these disorders, suggests a pre-clinical study from researchers at Penn Medicine and Mayo Clinic.

Inhibition of sphingolipid metabolism and neurodegenerative diseases
Disrupting the production of a class of lipids known as sphingolipids in neurons improved symptoms of neurodegeneration and increased survival in a mouse model.

How understanding the dynamics of yeast prions can shed light on neurodegenerative diseases
How understanding the dynamics of yeast prions can shed light on neurodegenerative diseases

New family of molecules to join altered receptors in neurodegenerative diseases
An article published in the Journal of Medicinal Chemistry shows a new family of molecules with high affinity to join imidazoline receptors, which are altered in the brain of those patients with neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's.

Examining diagnoses of stress-related disorders, risk of neurodegenerative diseases
Researchers investigated how stress-related disorders (such as posttraumatic stress disorder, adjustment disorder and stress reactions) were associated with risk for neurodegenerative diseases, including Alzheimer and Parkinson disease and amyotrophic lateral sclerosis (ALS), using data from national health registers in Sweden.

Toxic protein, linked to Alzheimer's and neurodegenerative diseases, exposed in new detail
The protein tau has long been implicated in Alzheimer's and a host of other debilitating brain diseases.

Study uncovers unexpected connection between gliomas, neurodegenerative diseases
New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer's, as a biomarker for glioma development.

Read More: Neurodegenerative Diseases News and Neurodegenerative Diseases Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.